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ABSTRACT: The opioid epidemic continues to be an ongoing public health crisis. Many primary health care providers aptly serve as the gatekeeper to opioid prescriptions. The opioid epidemic has challenged the primary care profession whilst many of these providers have opted out
of opioid prescribing altogether. This unintended consequence affirms erosion to primary care that is vital to the ecosystem of opioid management. The purpose of this study was to understand strategies to deliver opioids safely and effectively. Results indicate primary care providers
are uniquely positioned to make a positive opioid impact through focused change initiatives. Five common themes arose from the inductive
analysis: (1) provide leadership support; (2) define standard of work; (3) conduct pre-visit reviews; (4) conduct post-visit reviews; and (5) measure progress. Then, each common theme was deductively analyzed through a view of Kotter’s change theory to support an effective proxy for
implementing and sustaining chronic opioid therapy in a primary care context. These finding have potential to provide actionable implications
for health care management professionals and primary care organizations such as hospitals and group practices.
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Background

experiencing chronic non-cancer pain. There is reliable evidence the introduction of opioid guidelines for primary care
have had positive effect on overprescribing.7,8 Other evidence
suggests the implementation of opioid prescribing laws is not
associated with decline in prescription opioids.9 More importantly, there is credible proof the guideline left many chronic
pain patients stranded with inadequate analgesic coverage.10,11
Many patients experiencing chronic non-cancer pain continue
to have difficulty engaging a primary care practitioner for opioid management.2
Although the impact of the guidelines on opioid prescribing
practices have been studied extensively in many contexts,
including the primary care and community health settings,2,12-15
they have not paid much attention to case studies of successful
longitudinal transformations of opioid prescription practices in
primary care. Greater education about opioid management in
primary care remains an emergent alarm.16 The question
remains, how can primary care settings successfully transform
and sustain their opioid prescription practices while maintaining integrity and cohesiveness of patient care? The purpose of
this qualitative single case study was to identify and describe
the challenges that must be addressed by primary care to reduce
and sustain responsible opioid prescription practices. To do
this, we examined the experiences of medical providers and
support staff of a primary healthcare clinic that successfully
transformed their opioid prescriptive practices over a 5-year
period by using Kotter’s17 change theory as the framework of
their transition. Kotter’s change theory is a top-down approach
to change that engenders sequential steps to effectively prepare
and build acceptability of change in organizational personnel.
Kotter described 8 steps to an effective change process: (1)

Substance abuse disorder remains a primary public health crisis.1 Over 10 million Americans take prescription opioids for
pain relief. Many primary health care providers serve as the
gatekeeper to this pain. In recent years, the opioid epidemic has
challenged the primary care profession whilst many of these
providers have opted out of opioid prescribing altogether.2
There is evidence this exodus has had inadvertent consequence
for patients with chronic non-cancer pain. Many of these
patients have turned to illicit substances and have limited oversight of their concomitant health comorbidities.3,4 This selfconversion can have spillover effects for the community in the
way of people’s ability to work and be financially healthy, life
expectancy, educational attainment, safety and crime, and overall quality of life. This unintended cycle affirms primary care
providers are vital to the ecosystem of opioids and community
health. There remains a gap in understanding processes by
which primary care providers can deliver opioids safely and
effectively.5
On November 26, 2017 the Acting Secretary of Health and
Human Services declared that a nationwide public health
emergency existed as a consequence of the Unites States (U.S.)
opioid crisis. In 2020 over 93 000 overdose deaths were reported
in the U.S., a 29% increase from 2019.6 The ongoing epidemic
of prescription opioid misuse, addiction, and overdose remains
a public health crisis despite the issuance of the Center for
Disease Control and Prevention (CDC) guideline aimed at
helping primary care providers prescribe opioids for non-cancer pain.1 The guideline is most noted for the recommendation
that primary care providers should consider a daily cutoff rate
of 90 morphine milligram equivalents (MME) for patients
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establishing a sense of urgency; (2) create a guiding coalition;
(3) develop a vision and strategy; (4) communicate the change
vision; (5) empower broad-based action; (6) generate shortterm wins; (7) consolidate gains and produce more change; and
(8) anchor new approaches in the organizational culture. The
following research questions (RQ) guided our study:
(RQ1) How was change theory used as a basis for transitioning opioid prescription practices in primary care?
(RQ2) What challenges were identified when reducing opioid prescriptions in primary care?
(RQ3) How can reduction of opioid prescription practices
be sustained in primary care?

Methods

A case study was adopted to obtain rich and naturalistic data
from the participants.18 Yin19 emphasized case study research
is most relevant when it investigates a phenomenon within its
real-life context. Data collection included qualitative data from
participant experiences, quantitative data from 2 opioid risk
questionnaires, and participants’ daily MME values. The qualitative data investigated the phenomenon of sustained reduction in daily MME in a primary care context using inductive
analysis of participant interviews.19 The quantitative analysis
included participant intake scores on the Opioid Risk Tool
(ORT) and Screener and Opioid Assessment for Patients with
Pain-Revised (SOAPP-R) questionnaires along with daily
MME values for each year under study.

Participants
Participants were recruited from a local primary care clinic in
Northeast Texas. Seven participants were included in the study
through purposeful sampling.20 Audio recorded participant
interviews ranged from 42 to 66 minutes. The participants
consisted of multidisciplinary providers and ancillary staff
members who were instrumental to the change initiative in this
case study (Table 1). The majority (57.2%) of participants were
female and/or White. The average participant health care
experience was 18.6 years.

Data collection
Data were collected through semi-structured interviews (audio
recordings and field notes)21 made up of questions that aligned
with the purpose of the study.20 Participants read a letter of
consent to be interviewed. Interviews were guided by an interview protocol using an interview guide that included primary
questions that were open-ended and follow-up questions.20
The interview questions were constructed to discover aspects
of the participants’ experience that may add value to the study.22
Primary questions included background information, primary

Table 1. Participant interview demographics (n = 7).
Characteristic

Mean

Range

Age, y

38.4

23-68

Years of experience

18.6

4-39

Male

3

42.8

Female

4

57.2

White

4

57.2

Black/African American

2

28.5

Hispanic

1

14.3

Doctor of Osteopathic Medicine

1

14.3

Doctor of Chiropractic Medicine

1

14.3

1

14.3

Licensed Professional Counselor

1

14.3

Licensed Vocational Nurse

2

28.5

Medical Assistant

1

14.3

Gender distribution (n) (%)

Ethnicity (n) (%)

Degree (n) (%)

 Nurse Practitioner

care experiences, and questions about the change initiative to
reduce and sustain daily MME. Follow-up questions were used
to obtain further details about the primary questions and how
they related to Kotter’s change theory. A deidentified code was
used to preserve the anonymity of the participants. The interviews were transcribed by a professional transcriptionist and
were reviewed for accuracy of the data for analysis.22 Patient
specific ORT, SOAPP-R, and MME data was extracted from
the clinics MicroMD® electronic medical records software for
each year under study and assimilated in Microsoft Excel® for
analysis.

Data analysis
The qualitative data analysis used an inductive coding approach
identifying underlying ideas and concepts to result coding of
common themes. Themes were considered when ideas and
concepts emerged as recurrent in relation to the research questions.23 As a form of member checking, the themes were shared
with participants to provide opportunity for participant feedback and confirm that the participants’ experiences resonated
with the findings. Once common themes were identified, we
deductively classified each theme for observed social processes
that could be classified as rudiments of Kotter’s change theory.
Any intersubjectivity led to supplementary category classifications until agreement that the deductive coding remained
faithful to the theory.

Carpenter et al
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Table 2. Common themes for transforming opioid therapy with Kotter’s change theory.
Common themes

Description

Action steps

Kotter’s change theory

Provide leadership
support

Leadership that can build
organization-wide consensus for
prioritize safe opioid prescribing.

Identify change agent (coalition team) to
spearhead practice change initiatives.

Create a sense of urgency
Build a core coalition

Define standard of
work

Revise and implement opioid
therapy policies and define
standard of work for providers and
staff to achieve safer opioid
prescribing.

Convene team from each clinic department to
create and communicate the change initiative.
Update patient agreement and revise to ensure
alignment with clinic and guideline policies.

Develop a vision and
strategy
Communicate the strategic
vision
Empower broad-based
action

Conduct pre-visit
reviews

Conduct pre-visit planning and
screening for comorbidities and
prescription aberrancies.

Review outside medical records.
Review state prescription monitoring program
patient data.
Implement new patient exclusion criteria.

Generate short-term wins.

Conduct post-visit
reviews

Conduct post-visit chart reviews
for opioid outliers.

Monitor and adjust opioid therapy based upon
function not pain scale.
Conduct team reviews of outliers for consensus
of care.
Discharge outliers to improve staff efficiencies.
Identify referral sources for behavior and mental
health (eg, opioid abuse disorder).

Consolidate gains and
produce more change.

Measure progress

Continuously monitor progress
and improve with experience.

Identify key processes and outcome measures
to monitor change implementation.
Monitor prescription practices, provide and
discussing data with medical providers and
support staff at regular meetings (no less then
monthly).

Anchor new approaches in
the corporate culture.

Analysis of patient opioid risk tools (ORT, SOAPP-R)
spanned a 5-year period and captured the initial psychometric
properties of each participant’s predisposition to opioid abuse.
These measures were important to establish a baseline for predicting aberrant behaviors that may impact opioid compliance.
Analysis of patient MME data spanned a 5-year period. Data
for each year included any patient who was prescribed at least
1 narcotic prescription. Patients with daily MME less than
5 mg were excluded from the study. Following data extraction
from MicroMD®, each year of interest for ORT, SOAPP-R,
and MME was categorized in Microsoft Excel® for analysis.

Results

Five common themes arose from the inductive analysis: (1)
provide leadership support; (2) define standard of work; (3)
conduct pre-visit reviews; (4) conduct post-visit reviews; and
(5) measure progress. Upon presentation of the common
themes to the participants, all expressed support for the findings. The deductive analysis of each common theme was oriented and classified until agreement that the deductive coding
remained faithful to Kotter’s change theory (Table 2).
Analysis of the ORT revealed the mean participant intake
score was 3.6. A score of 3 or lower indicates low risk, a score of
4 to 7 indicates moderate risk, and a score of 8 or higher indicates a high risk for opioid abuse. The mean participant intake
score for the SOAPP-R was 9.2. A score >9 lower indicates
low risk, a score of 10 to 21 indicates moderate risk, and a score

of 22 or higher indicates a high risk for opioid abuse.
Importantly, the mean intake scores of each opioid risk tool
remained fairly consistent each year under study (ORT range
3.3-4.0; SOAPP-R range 7.8-11.4).
Analysis of patient MME data spanned a 5-year period.
The daily dosage per opioid therapy patient the year prior to
the CDC guideline (April 2015-March 2016) was well above
the ⩾90 daily MME threshold (μ1 = 102.5 mg). The year following the CDC guideline showed a reduction in daily MME
by 13% (μ2 = 88.5 mg) with year 3 (μ3 = 74.0 mg), 4 (μ4 = 60.5 mg),
and 5 (μ5 = 45.0) showing greater annual reduction percentages
respectively. Overall, the clinic was able to reduce daily MME
by 56% in 5 years (Table 3) while maintaining total annual
clinic patient visit volume.

Discussion

The opioid epidemic continues to challenge the primary care
profession. There remains need to identify effective strategies
to deliver opioids safely and effectively. This study presented
evidence that change theory may be useful as a framework to
reduce and sustain daily MME in a primary care context. A
strategy that safely and effectively reduces opioid prescription
practices is important to the health of primary care patients,
primary care clinics, and communities. What follows is an
explication of common themes through a view of Kotter’s
change theory during pre-launch, launch, and post launch
phases to answer each research question (Table 4).
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Table 3. Mean MME daily dose per opioid therapy patient per year.
Milligram Morphine Equivalent (MME) per opioid patient
Date range

Mean (μ) (mg)

Annual percent (%) change

Total percent (%) change

April 2015-March 2016

102.5

0.00

0.00

April 2016-March 2017

88.5

13.65

13.65

April 2017-March 2018

74.0

16.38

27.80

April 2018-March 2019

60.5

18.24

40.98

April 2019-March 2020

45.0

25.62

56.02

Table 4. Common themes for transforming opioid therapy through launch phases.
Common themes

Kotter’s change theory

Provide leadership support

Create a sense of urgency

Pre-launch

Build a core coalition
Define standard of work

Develop a vision and strategy
Communicate the change vision
Empower broad-based action

Conduct pre-visit reviews

Generate short-term wins.

Conduct post-visit reviews

Consolidate gains and produce more change.

Measure progress

Anchor new approaches in the corporate culture.

Pre-launch
Pre-launch was considered efforts that included any preparation
for or preliminary activity prior to the launch. Participants were
consistent in their belief that pre-launch was the most important phase for successfully transitioning opioid prescription
practices. Data included in the pre-launch phase provided
insight to answer RQ1: how was change theory used as a basis
for transitioning opioid prescription practices in primary care?
Providing leadership support and defining standard of work
were important common themes for underpinning the prelaunch phase. Providing leadership support was deductively
considered a characteristic of Kotter’s change theory through
creating a sense of urgency and building a core coalition.
Whereas defining standard of work was deductively considered
a characteristic of Kotter’s change theory through developing a
vision and strategy, communicating the strategic vision and then
empowering broad-based action.

Creating a sense of urgency
“We’ve became keenly aware of the opioid research and the regulatory oversight that comes with prescribing opioids. We knew proving
opioids had a lot of associated risk and that there were better ways to
manage chronic pain. . .and the CDC solidif ied that urgency
for us.”—Doctor

Launch

Post-launch

The CDC guideline created a sense of urgency in the delivery
of opioids for chronic pain.6 The guideline provided recommendations for prescription practices outside of active cancer treatment, palliative care, or end-of-life care. Most importantly was
concern that daily MME greater than 90 mg would not be considered standard of care. The guideline initiated need for implicit
provider compliance. Participants expressed fear of balancing
regulatory oversight with effective daily MME prescribing.24
Titrating daily MME had potential for patient exodus or selfconversion to illicit substances that could impart deleterious
effects on the patient, practice, and community. The urgency
shifted to how to strategically undertake this task. Providing
leadership support and defining standard of work were instrumental aspects to guide participants through urgency pressures.
A team was needed to lead the change initiative.

Building a core coalition
“It was most certainly one of those ‘everybody gets involved’ changes,
because we needed everyone in the clinic to understand what we were
attempting to do.”—Licensed Professional Counselor

A central team was developed to help lead creation and implementation of the change initiative. Participant’s communicated
that strong leadership was essential in driving change—by

Carpenter et al
prioritizing work and facilitating a consensus-building process
for conversion. The central team included the clinic administrator, medical director, and licensed professional counselor. It was
created to identify avenues that would be most effective for
implementing the initiative. The central team considered different aspects of the change process, including unintended consequences and championed the initiative with a framework that
included a core coalition. Coalition members were identified
based upon their roles and responsibilities. The members represented a cross-section of clinic staff (the core coalition members
represent the participants in this study; Table 1). This approach
afforded opportunity to engage various clinic stakeholders in its
creation and facilitated stakeholder buy-in throughout the
organization.

Developing the strategic vision
“It didn’t take long for everyone to understand the strategy. We were
going to develop this new change agenda, sort of a clinic roadmap if you
will, and this agenda would dictate exactly how we managed opioids for
the safety of our patients and the safety of our medical license.”—Medical Provider

A strategic vision involves developing the action plan of the
organization. It was important for the coalition to have a shared
understanding of the clinic’s strategic vision and approach to
change. The strategic vision interconnected the need to change
with the path to change. It incorporated objectives to address
tools for providers to treat chronic pain with opioid therapy safely
and compassionately. Internal policies would be standardized to
ensure consistent prescribing practices that met common challenges in chronic pain management. The vision functioned to
promote best practices through practice improvement programs,
technical assistance (coaching), and literature review that facilitated efficacy and ensured compliance with Centers for Medicare
& Medicaid Services fraud, waste, and abuse policies and with
Drug Enforcement Administration rules. The vision served to
illustrate high levels of strategic alignment relative to both the
external and internal opioid prescription initiatives and provided
frequent review policies to maintain compliance. The strategic
vision represented the crafting and formulating of short-term and
long-term initiatives directed at attaining organizational objectives. Next, it was important to get everyone on board.

Communicating the strategic vision
“ Yeah, it was talked about all the time and everyone knew they had to
get on board with managing these patients better. The patients needed
it and we needed it as a staff. We were all working together with these
patients and their concerns, and there were a lot of concerns. We really
needed to understand how this was going to happen”—Nurse

Much of organizational change will not succeed without
people adopting new ways of working.25 One of the primary
reasons employees resist change is their failure to understand
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how change will occur. It is vital to any change management to
reduce conflict and increase collaboration through communication. Organizations enacting change policies tend to focus on
what has to be done and by when. Often, management does
not follow through with the necessary communication employees need to achieve the desired results.26 Communicating the
strategic vision was important in order to assess employee readiness for change and to precisely recognize change barriers.27 In
developing the strategic vision the participants specified it was
important to create reporting protocols and communication
accountability. It was essential that the implementation plan
clearly communicated responsibility, accountability, timeline
expectations, and shared transparencies to understand desired
outcomes of the change initiative.

Empower broad-based action
“. . .we had some disagreements on how to wean some of the patients
down. There were different ideas and such. . .ultimately, we went to
the literature and pulled down some references so that we could tie our
titration methods back to other guidelines. At the end of the day, we
needed something to fall back on that was central to the actions we
needed.”—Medical

Removing barriers and reducing friction is essential to any
successful broad based action within an organizational.28
Participants identified 2 primary obstacles that were encountered during communication of the strategic vision. First,
incongruous weaning methodologies were acknowledged
between prescribers. The providers were from different generational medical backgrounds which culminated in dichotomous
treatment opinions. Second, a sense of perturbation was offered
by all providers when engaging patient needs during MME
reduction. Concerns ranged from, “push back” or resistance by
the patient, extended time to implement prescribing changes
for each patient, detoxification comorbidities, and illicit substituting to manage chronic pain. Key to removing barriers was to
address how concrete solutions would be introduced mitigating
aforementioned provider concerns. Consolidating barriers that
linked to operational clarity and consistency of norms for the
launch phase was instrumental to sanctioning broad-based
conformity and empowered action.
Launch. The launch considered labors that afforded operationalizing the change initiative. Although promoting change
readiness in the pre-launch phase was vital, participants
expressed the launch phase was the most challenging phase of
the change process. Gilley et al28 asserted that 30% to 60% of
all change initiatives fail within organizations. Despite a clear
understanding of the major initiatives, unintended consequences can plague organizational change strategy.29 Here,
data were used to categorize the launch phase and provide
insight to answer RQ2: what challenges were identified when
reducing opioid prescriptions in primary care? Conducting pre
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and post-visit reviews and measuring progress were important
common themes for underpinning the launch phase. Each
common theme gave impetus to incorporate the Kotter’s elements of short-term wins and consolidated gains. Important to
the success of any change initiative is positive momentum.28
Participants considered any incremental reduction in daily
MME a condition of positive momentum.

Generating short-term wins
“We had some difficult patients at first, overall though; it was good to
see some of these patients react to being able to function on less medication. I remember one patient was like ‘I feel like my mind is clearer’
because she was able to complete puzzles better. That little change was
exciting for her and for us.”—Licensed Professional Counselor

The change initiative was launched with an action plan coupled with training sessions on clarity of activities, responsibilities, and expected timeframes. Each section of the action plan
(eg, new patient acceptance criteria, initiation of opioid therapy,
policy for refills, short-acting opioids, polypharmacy) was conditioned by identifying the skill set and knowledge level of the
clinic staff impacted by each section. Prerequisite knowledge
and support materials were provided for rapid knowledge
acquisition. Following each training session, open dialog was
helpful to formalize processes and establish new cultural norms.
Participants expressed resistance to the launch was more widespread than expected. We interpret this stage of resistance to be
in line with Erwin’s30 findings that some healthcare employees
are unprepared or simply decline to learn and develop new
skills. To overcome any reluctance the staff was encouraged to
expressly highlight moments of improvement (eg, operational
efficacies and/or MME reductions) as short-term wins to be
celebrated. Overtly recognizing positive change events helped
to encourage conformity and adoption.

Consolidate gains and produce more change
“Once we got patients down to 90mg we were like, let’s keep going. We
were able to decrease some of the patients by 50-60%. I personally have
seen more patient visits since we initiated the MME reduction because
now alternative treatments are on the brain, not just more
pills.”—Chiropractor

Keeping the change effort viable is important. There must
be concerted efforts to reinforce momentum of the change initiative. To do this, the coalition made it a point to consolidate
the gains from previous short-term wins. Weekly meetings
were used to demonstrate visual cues that provided a more tangible optic on their achievements. This view was instrumental
in countering any continued resistance and kept the staff motivated to be engaged without sliding back to the old ways of
doing things. Preventing recalcitrant behavior was central at
this stage. The weekly meetings provided an open platform for

softening resistance points by including ways to “bake in”
potential barriers and incorporate them into processes for more
change. For example, early in the launch phase it was discovered the fear of patient resistance to MME reduction continued. This fear was addressed by abdication of a unimodal
approach and incorporated multimodal treatment strategies to
pain control. A licensed professional counselor was included to
concurrently manage patients with psychosocial overlay concomitants. Detoxification comorbidities were supported with a
“prescription pack” for treatment of opioid abstinence syndrome (ie, withdrawal) and was made available to the patient at
the time of visit. The ability to consolidate gains, make adjustment, and incorporate new prospects for change gave opportunity for sustained acceleration of the change initiative.
Post launch. The post-launch was considered work that promoted lasting change to the prescriptive culture. Failure to
implement lasting change frequently occurs unless there has
been change in organizational culture.28 Anchoring change to
the culture with new norms and values that supported the
change effort was important in this phase. In order to solidify
change in the culture, the change effort needed to demonstrate
positive organizational results. Data from the post-launch
phase provided insight to RQ3: how was reduction of opioid
prescription practices sustained in primary care? Similar to the
launch phase, measuring progress was significant for the postlaunch phase. It was important to measure progress to solidify
Kotter’s eighth step; anchor new approaches in the organizational culture.

Anchoring to the culture
“We continue to evolve our behaviors to promote stability in our opioid
management practices. When something new comes up we meet on it
and determine how it will be addressed and add that to our way of
doing things. We also meet monthly to go over difficult patients and
different procedures we need to modify. It keeps the team on their toes
and has made us a much better clinic.”—Nurse Practitioner

The post launch strategy was to shift the emphasis from
maintenance to sustained improvement. Kotter stressed the
point that sustained change must be anchored in order for
change to take place successfully. The indoctrination of new
norms of behavior and shared prescribing values were important
to anchor to the culture. In this phase the core coalition provided
continued leadership and reinforced new practices to anchor the
transformation into the culture. Participants indicated sustainability occurred when the new culture began to exert itself on
resistant staff members and new hires. Linking the new norms
with core capabilities was instrumental in the opportunity to
solidify the process away from people’s tendency to revert to the
old and comfortable ways of doing things. The new culture
served as a reinforcing tool regarding the risks associated with
continuing to prescribe opioids and reinforced signs of misuse,
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abuse, or diversion that can result in (1) patient overdose and
death, (2) negative community health byproducts like crime or
motor vehicle accidents; and (3) implications for state and federal licensure. Built-in motivation to keep the patients, the
organization, and the community safe and healthy was anchored
into operations to help facilitate the opioid change initiative.

Conclusion

An ongoing challenge to the opioid crisis continues in large
health care systems and rural clinics that treat and manage
patients with opioids.31,32 Primary care providers are uniquely
positioned to make positive impacts on the opioid crisis with
planned change. Planned change in primary care is necessary,
but change can be challenging to implement—especially in the
context of chronic opioid therapy. The case study demonstrated
a reduction in MME from 102.5 mg in 2015 to 45.0 mg in
2020 accounting for a 56% reduction over a 5-year period. The
reduction in daily MME was concurrently successful in maintaining patient population and minimizing abuse, misuse, or
diversion of opioids or illegal substances that may have potential deleterious effect on community health. Importantly, the
psychometric properties of the 2 opioid risk tools (ORT,
SOAPP-R) administered at intake for each participant revealed
the category of potential aberrant behavior (low to moderate)
was consistent over the 5 period under study. This analysis adds
support to suggest the successful conversion was accomplished
through planned change and adoption of change theory as a
framework to a change initiative. An established process for
continuous improvement was imperative for anchoring longterm cumulative gains over time. Ongoing monitoring and
review of clinic policies to support management of opioid therapy has continued to provide sustainable benefits (Table 5). For
example, as a byproduct of the change, clinic production was
streamlined by eliminating outlier patients (eg, early refill
requests, aberrant drug screens). Moreover, documentation
efficiencies were gained due to treatment boundaries and
parameters that severed to reduce costs of care.
The findings in this study demonstrate Kotter’s theoretical
framework an effective tool for implementing and sustaining
transformational change in a primary care practices treating
and managing patients with chronic opioid therapy. These
finding have the potential to provide actionable implications
for health care management professionals and primary care
organizations such as hospitals and group practices.

Research limitations of the study
Rich data were obtained from the participant interviews that
were conducted. However, data regarding the change initiative
was absent any patient perspective—thus omitting a potentially valuable perspective on this research. Although the quantitative data was important to validate reduction in MME in
participants with consistent opioid risk tendencies over the
5 year period, the data was devoid of urinary drug screen
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Table 5. Ongoing monitoring to support chronic opioid therapy in
primary care.
New patient acceptance criteria
Absolute contraindications
   Severe respiratory instability
   Acute psychiatric instability or uncontrolled suicide risk
  True allergy to opioid agents (cannot be resolved by
switching agents)
   Serious adverse effects that cannot be treated
   Illicit drug conviction
Relative contraindications
   Medical condition in which COT may cause harm (eg, COPD)
  Complicated pain (eg, headache not responsive to other pain
treatment modalities)
   Psychosocial behavioral overlay conditions
Prior to initiation of COT
Review of prior medical records
Establishment diagnosis that justifies COT
Review patients PAT for inconsistencies
Urinary drug screen
Screen and assess the patient’s risk (SOAPP-R, ORT)
Signed pain management agreement
Only use 1 pharmacy
Only 1 provider
Established patient currently on COT
Signed pain management agreement
Random urinary drug screen
Review patients PAT for inconsistencies
 No early refills
Police report for all lost prescriptions
30-D supply only
Monitor for co-prescribing of sedatives
Others
 Naloxone prescribed to all patients >50 mg MEDD
 Established protocol of referral to interventionalist or mental
health specialist (eg, aberrant behavior, >90 mg MEDD)
 Primary goal of treatment should be clinically significant
improvement in function
Abbreviations: COPD, chronic obstructive pulmonary disease; COT, chronic
opioid therapy; MEDD, morphine equivalent daily dose; ORT, opioid risk tool;
PAT, prescription access in Texas database; SOAPP-R, screener and opioid
assessment for patients with pain-revised.

constancies/inconsistencies that may have provided further
confirmation of change theory success in the primary care context. Furthermore, this case study only sought participants
from the Northeast Texas region of the United States which
limits generalizability. The sample size was small and further
limits the potential to generalize the findings.
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